Adbelimumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Adbelimumab, covering 2024-08-06 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma. [Phase 2]